Investing News Network

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration’s approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

SourceThe Life Sciences Report (5/2/2013)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration’s approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

MARKETS

Markets
TSX18658.36-20.28
TSXV594.42+1.72
DOW30873.97-107.36
S&P 5003815.82-2.98
NASD11288.93+24.20
ASX6606.30+4.10

COMMODITIES

Commodities
Gold1738.91+13.61
Silver19.30+0.41
Copper3.33+0.05
Palladium1987.00-32.00
Platinum857.50+16.50
Oil96.38+0.54
Heating Oil3.67+0.01
Natural Gas6.72+0.55

DOWNLOAD FREE REPORTS

×